These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29318515)

  • 1. A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.
    Coates M; Spanos M; Parmar P; Chandrasekhar T; Sikich L
    Drug Saf; 2018 May; 41(5):465-471. PubMed ID: 29318515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology.
    Greenhill LL; Vitiello B; Fisher P; Levine J; Davies M; Abikoff H; Chrisman AK; Chuang S; Findling RL; March J; Scahill L; Walkup J; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2004 Dec; 43(12):1488-96. PubMed ID: 15564818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of safety assessment methods used in pediatric psychopharmacology.
    Greenhill LL; Vitiello B; Riddle MA; Fisher P; Shockey E; March JS; Levine J; Fried J; Abikoff H; Zito JM; McCracken JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Walkup JT; Capasso L; Rosengarten J
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):627-33. PubMed ID: 12921469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety methodology in pediatric psychopharmacology trials.
    Yuill K; Carandang C
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):148-62. PubMed ID: 23607408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns.
    Hughes S; Cohen D; Johnson R
    Int J Risk Saf Med; 2016 Aug; 28(2):101-14. PubMed ID: 27567767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Effects of Psychotropic Medications: A Call to Action.
    Mago R
    Psychiatr Clin North Am; 2016 Sep; 39(3):361-73. PubMed ID: 27514294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.
    Basch E; Rogak LJ; Dueck AC
    Clin Ther; 2016 Apr; 38(4):821-30. PubMed ID: 27045992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
    Talat B; Mayers A; Baldwin DS
    Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
    Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to evaluate side effects in a clinical trial?].
    Maurel M; Belzeaux R; Adida M; Azorin JM
    Encephale; 2016 Dec; 42(6S):S30-S32. PubMed ID: 28236990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research.
    Rabkin JG; Markowitz JS; Ocepek-Welikson K; Wager SS
    J Clin Psychopharmacol; 1992 Feb; 12(1):3-10. PubMed ID: 1552037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we improve the assessment of safety in child and adolescent psychopharmacology?
    Vitiello B; Riddle MA; Greenhill LL; March JS; Levine J; Schachar RJ; Abikoff H; Zito JM; McCracken JT; Walkup JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Capasso L
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):634-41. PubMed ID: 12921470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essentials for starting a pediatric clinical study (4): Clinical pediatric safety planning based on preclinical toxicity studies and pediatric pharmacovigilance guidance.
    Sheth N
    J Toxicol Sci; 2009; 34 Suppl 2():SP327-9. PubMed ID: 19571487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of adverse event reporting in companion animal clinical trials evaluating cancer treatment.
    Giuffrida MA
    J Am Vet Med Assoc; 2016 Nov; 249(9):1079-1087. PubMed ID: 27767430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core Concepts Involving Adverse Psychotropic Drug Effects: Assessment, Implications, and Management.
    Goldberg JF; Ernst CL
    Psychiatr Clin North Am; 2016 Sep; 39(3):375-89. PubMed ID: 27514295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.
    Hunsinger M; Smith SM; Rothstein D; McKeown A; Parkhurst M; Hertz S; Katz NP; Lin AH; McDermott MP; Rappaport BA; Turk DC; Dworkin RH
    Pain; 2014 Nov; 155(11):2253-62. PubMed ID: 25123543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the assessment of psychotropic drug harms in clinical trials to improve social workers' role in medication monitoring.
    Hughes S; Cohen D
    Soc Work; 2010 Apr; 55(2):105-15. PubMed ID: 20408352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy.
    Vaughan B; Goldstein MH; Alikakos M; Cohen LJ; Serby MJ
    Compr Psychiatry; 2014 May; 55(4):849-55. PubMed ID: 24630200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
    Aagaard L; Hallgreen CE; Hansen EH
    Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology.
    Grabb MC; Gobburu JVS
    Prog Neurobiol; 2017 May; 152():38-57. PubMed ID: 27216638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.